Glucocorticoids affect the composition and function of the plasma membrane in a variety of cell types.' Incubation of HTC cells, an established line of rat hepatoma cells in tissue culture, with the synthetic glucocorticoid dexamethasone (DEX) alters several membrane properties characteristic of transformed cells, without affecting the growth rate of these cells. Dexamethasone rapidly and reversibly inhibits the active transport of selected amino increases the adhesiveness of the cells to a plastic or glass substrate by a process that requires macromolecular and rapidly and dramatically inhibits the activity of plasminogen activator (PA), a serine protease, which may itself modulate other membrane proper tie^.'^'^ HTC cells provide a favorable experimental system for the investigation of the hormonal regulation of membrane phenotype. The effects of individual hormones, either in isolation or in combination, can be studied in a fashion that is not possible in the intact animal. An established cell line offers the ease of experimental manipulation and stability under a variety of experimental conditions, not usually available in freshly-isolated dissociated cells or in primary cultures of liver cells. The ability to grow HTC cells in suspension culture reduces the need for manipulations such as trypsinization, which can affect transport and other membrane processes. HTC cells have been studied intensively with regard to glucocorticoid receptor function and induction of tyrosine aminotransferase which further enhances their usefulness for our studies. Finally, as discussed in this communication, it is possible to isolate steroid-resistant variant lines of HTC cells allowing the application of both genetic and biochemical techniques to the study of the hormonal regulation of membrane properties in these liver-derived cells.
Glucocorticoid Regulation of Amino Acid Transport in HTC Cells
We have studied the transport of amino acids by HTC cells in suspension culture utilizing the model amino acid a-aminoisobutyric acid (AIB). AIB is transported in a number of tissues by the so-called A, or alanine-preferring, system for neutral amino acids.I7 Following uptake, AIB is neither incorporated into protein nor catabolized; hence its transport can be studied independently of the complications introduced by such intracellular metabolism. Subsequently, we have extended our studies to the hormonal modulation of the transport of natural amino acids. HTC cells in suspension culture in a chemically-defined, serum-free medium containing essential amino acids and glucose, actively transport AIB by saturable, stereospecific, energy-dependent process. Distribution ratios greater than 20 are achieved at AIB concentrations of less than 0.5 mM. A single sodium-dependent transport system appears to mediate the bulk of AIB uptake. The apparent Km for this system is I to 3 mM.2,s Dexamethasone rapidly and dramatically decreases the influx of AIB. Following a lag of approximately one-half hour, the initial rate of transport decreases exponentially to approximately 20% of control after 6 hours, and 10% after 18 hours incubation with hormone. Inhibition is half-maximal within 90 to 120 minutes (FIGURE 1). The inhibition of AIB transport by dexamethasone reflects a decrease in the capacity of the transport system, or its Vmax, without significant change in the apparent Km of the transport Removal of the hormone by washing and resuspension of the cells in glucocorticoid-free medium, reverses the inhibition of AIB transport. Recovery of control rates of transport occur within a roximately 20 hours; half-maximal recovery requires approximately 5 to 6 hours!' Incubation of dexamethasone-treated cells with insulin results in a rapid, strikin stimulation of AIB transport to or near control levels within 2 hours incubation. Jt?
Mechanism of Glucocorticoid Inhibition of Transport
The mechanism of the transport inhibition has been explored using a variety of inhibitors. Neither colcemid nor cytochalasin B, at concentrations sufficient to disaggregate microtubules and microfilaments, respectively, interferes with AIB transport nor its inhibition by dexamethasone. Thus, cytoskeletal elements do not appear to play an important role in the hormonal inhibition of AIB transport.' the dexamethasone inhibition of transport. Curiously, cycloheximide alone only minimally inhibits the uptake of AIB. Cycloheximide also blocks the recovery of AIB transport following removal of dexamethasone. Furthermore, addition of cycloheximide 30, 60, or 120 minutes after the addition of dexamethasone completely prevents any further inhibition of AIB transport by the glucoc~rticoid.~ Lower concentrations of cycloheximide (1 pM), which inhibit amino acid incorporation into protein by 40% to 60%, do not prevent the dexamethasone inhibition of AIB transport, but do inhibit transport in the absence of dexamethasone.
Studies using actinomycin D to inhibit RNA synthesis have yielded similar results. Concentrations of actinomycin (0.2 pM) sufticient to inhibit the incorporation of uridine into RNA by 90% to 9596, inhibit AIB transport but do not interfere with the inhibition by de~amethasone.~ Higher concentrations of actinomycin D (4 pM), which block uridine incorporation by more than 95% (and cause "superinduction" of tyrosine aminotran~ferase'~) cause only a modest inhibition of AIB transport in control cells but completely prevent the dexamethasone inhibition of AIB transport; results similar to those obtained with 0. I mM cy~loheximide.~ High concentrations of both cycloheximide and actinomycin D have been reported to interfere with rotein degradation in HTC cells and other rat hepatoma cells in tissue culture?"2QWe feel that the experimental results described above are most compatible with the hypothesis that dexamethasone accelerates the degradation of some rate-limiting component of the AIB transport system. In the presence of high concentrations of cycloheximide or actinomycin D, degradation is blocked, and DEX action inhibited. This explanation is also consistent with the time course of the dexamethasone inhibition and its reversal after removing dexamethasone. It should be noted that an effect on degradation would result in more rapid changes in transport than a comparable effect on the rate of synthesis, since the time course of change from one steady state to another is a function only of the rate of degradation of the relevant protein. 24 
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Steroid Specificity of the Glucocorticoid Inhibition of Transport
We have also investigated the relationship between steroid structure and inhibition of AIB transport, and compared this with the steroid specificity of induction of tyrosine amin~transferase~~ and binding to specific cytoplasmic glucocorticoid receptorsz6 Our observations support the model of a common receptor system in the mechanism of action of glucocorticoids in HTC cells. Dexamethasone and cortisol, which are full agonists with respect to transaminase induction, are also full agonists with respect to transport inhibition. The concentrations required for half-maximal inhibition of transport, 5 nM for dexamethasone and 60 nM for cortisol, correspond almost exactly to those required for half-maximal induction of tyrosine aminotransferase. Tetrahydrocortisol, an inactive steroid because it neither binds to the cytoplasmic receptor nor induces transaminase, has no affect on either AIB transport or its inhibition by dexamethasone. Curiously, 1 1 -P-hydroxyprogesterone and deoxycorticosterone, which are partial agonists or "suboptimal inducers" of tyrosine aminotransferase, are, at sufficiently high concentrations, full agonists with respect to transport inhibition. Even 17-a-methyltestosterone, an "anti-inducer" of tyrosine aminotransferase, causes significant inhibition of AIB transport at high concentrations (0.1 mM). Competition experiments, in which the effects of increasing concentrations of partial agonists or antagonists together with a constant concentration of full agonist are examined, confirm the above results. The inhibition of amino acid transport by steroids that are partial agonists or antagonists for transaminase induction is not a generalized toxic effect of high concentrations of these steroids. Rather, they appear to share with dexamethasone common mechanisms of action in terms of their time course, reversibility, and inhibition by cycloheximide and actinomycin D.27 These observations imply more complexity then is currently encoded in the steric-allosteric model of steroid hormone action,% or in the nature of the postreceptor events as described by the widely accepted induction model of glucocorticoid a~t i o n . '~"~
Role of the Nucleus in Glucocorticoid Regulation of Transport
It is generally believed that nuclear localization of steroid-receptor complexes is necessary for their biological action^'^; however, the possibility that steroid-receptor complexes may have nonnuclear actions has not been excluded. At present there is direct evidence for nuclear localization of only full agonist glucocorticoids in HTC cells, and indeed there is some evidence that antagonists or anti-inducers do not enter the nucleus. 29 In order to study the possibility that the dexamethasone-receptor complex might have direct cytoplasmic actions, we have examined the dexamethasone regulation of AIB transport in anucleate HTC cells. HTC cells were enucleated by centrifugation through Ficoll gradients containing 10 pg/ml cytochalasin B.30
Preparations of cytoplasts containing more than 96% anucleate cells in yields of approximately 60% could be obtained readily. Washed cytoplasts could be maintained in suspension in serum-free medium for more than 24 hours without loss of membrane integrity, as assessed by the exclusion of trypan blue. Anucleate HTC cells transport AIB with initial rates of uptake equal to or greater than those of intact cells, for as long as 24 hours in culture. The time course of uptake and the kinetics of AIB transport are the same as those of intact cells. Dexamethasone, however, completely fails to inhibit AIB uptake in cytoplasts. Transport was also unaffected by deoxycorticosterone and 1 I -P-hydroxyprogesterone at concentrations that produced maximal inhibition of transport in nucleated ~ells.~'~3' The failure of dexamethasone inhibition of transport in anucleate HTC cells could not be accounted for by the decreased level of total protein synthesis in anucleate cells, nor by absence of specific glucocorticoid receptors. Thus the nucleus appears to be required for the glucocorticoid regulation of AIB transport in HTC cells. This may reflect the requirement for direct nuclear action of glucocorticoids, or a requirement for the nucleus for the maintenance of normal rates of protein d e g r a d a t i~n .~~
Amino Acid Specifcity of Glucocorticoid Inhibition of Transport
Dexamethasone also inhibits the initial rates of transport of several natural amino acids. The transport of gl cine, serine, alanine, and proline, amino acids transported mainly by the A system,' was inhibited 50% to 85% by dexamethasone. Transport of amino acids thought to be transported mainly by the L system (phenylalanine, leucine, and valine) was also inhibited, although to a lesser extent. Detailed kinetic analysis of glycine transport by hepatoma cells revealed at least two separate transport systems. One system is characterized by low afinity (Km = 5.1 mM) and high capacity for glycine transport. This system appears to be analogous to the A-transport system described in other cell types because it is sodium and pH-dependent, and mediates the bulk of AIB transport. The other transport system is characterized by higher affinity (Km = 0.23 mM) and lower capacity for glycine transport, is also sodium-dependent, but is not inhibited at low pH. The pattern of inhibition of the latter system by various amino acids and analogs differs from that of any previously characterized transport system in animal cells. Both transport systems for glycine are strikingly inhibited by dexamethasone; however, the time course of the glucocorticoid inhibition of the low-affinity, high-capacity system is much more rapid. Glutamic acid uptake by HTC cells is also markedly inhibited by dexamethasone, and appears to be mediated by one or more transport agencies distinct from either of the glycine transport systems. Therefore, dexamethasone appears to inhibit the activity of at least three discrete amino acid transport systems in rat hepatoma cells.6 This finding is in contrast to the generally held belief that hormones and other modulators of transport affect solely or primarily the A system.% Annals New York Academy of Sciences
Glucocorticoid Regulation of Plasminogen Activator
Many transformed cells roduce increased amounts of proteolytic enzymes, such as plasminogen activator?'*' The production of such proteases has received special attention because of the pleiotropic effects of these enzymes on membrane structure and function, and because of their important role in biological Proteolytic removal or alteration of a limited number of membrane proteins could have diverse effects on the behavior of many cell surface proteins, by influencing either their mobility within the membrane or their interaction with each other and with the interior of the cell.
Wigler et al. first reported that HTC cells produced large amounts of plasminogen activator, and that this activity is dramatically and rapidly inhibited by treatment of the cells with dexamethasone." We have confirmed these observations and have investigated the mechanism by which glucocorticoids inhibit the activity of this serine protease. The time course of inhibition of intracellular PA activity by dexamethasone is shown in FIGURE 2. PA activity is measured by the solubilization of '251-fibrin; fibrinolytic activity in HTC cells is entirely dependent on the presence of plasminogen. Dexamethasone, after a short lag, causes a rapid inhibition of PA activity, which is maximal in 3 to 5 hours and is half-maximal after approximately 90 minutes incubation with the hormone. The direct addition of dexamethasone to the assay has no effect on fibrinolytic activity.I2
The inhibition of plasminogen activator could involve a decrease in the amount of PA secondary to a decrease in its rate of synthesis or increase in its rate of degradation, or the induction of an inhibitor of PA activity, or a combination of these mechanisms. Mixing experiments were carried out in which increasing amounts of cell extracts of hormone-treated cells were incubated with a constant amount of cell extract of untreated cells as a source of PA activity. The concentration-dependent inhibition of PA activity in such mixtures revealed the presence of an inhibitory activity in dexamethasone-treated cells.12 Cell fractionation experiments indicated that PA activity is localized to the particulate (lo0,OOO X g pellet) fraction whereas the inhibitory activity is found primarily in the soluble cytoplasmic fraction (1o0,OOO x g supernatant). However, inhibitory activity is also found in the particulate fraction, and in the serum-free medium conditioned by dexamethasone-treated cells.
Genetic Approaches to the Hormonal Regulation of Plasma Membrane Phenorype
In order to investigate the mechanisms by which steroids induce the membrane changes described above, it would be helpful to have mutants or variants resistant to the regulatory effects of glucocorticoids. Since glucocorticoids do not kill or alter the growth or plating efficiency of HTC cells on plastic or in agar,'3s38 there are no obvious selective systems by which to isolate dexamethasone-resistant cells. Instead, we have utilized an agar-fibrin overlay techniquem to detect the production of Time (hrs) The degree of glucocorticoid resistance of these three lines is illustrated in FIGURE 3.
PA activity in wild-type cells is half-maximally inhibited by 5 nM dexamethasone and completely inhibited by concentrations greater than 10 nM. Variant cell lines are fully resistant to concentrations of dexamethasone 1,OOO times those required to completely inhibit PA activity in wild-type cells. 13 Each variant appears to possess distinct morphology; however, there appears to be no single consistent morphology associated with resistance to dexamethasone inhibition of PA activity. The cloning efficiencies of 3 variant lines tested is the same as that of wild-type cells (40% to 600/0), and in no case are these efficiencies altered by dexamethasone. The growth of wild-type and variant cells in both monolayer and suspension culture appears to be the same. Thus regulation of rowth and regulation
The origin of the resistant phenotype is not entirely clear. Fluctuation analyses demonstrate that the dexamethasone-resistant phenotype arises at random and is present prior to exposure to the hormone. Thus the variants are not induced by exposure to dexamethasone. On the other hand, neither chemical (ethyl methanesulfonate) nor physical (ultraviolet light) mutagens detectably increased the frequency with which the dexamethasone-resistant phenotype is observed. These observations argue against mutations as the primary cause of resistance to dexamethasone. Because HTC cells are heteroploid and karyotypically highly variable, variants are thought to arise primarily by chromosomal segregation events. 13 The mechanism of resistance to dexamethasone inhibition of plasminogen activator in the variant cell lines could be the result of a failure of the hormone to induce the inhibitor, or to the production of a plasminogen activator that is resistant to the action of the inhibitor. We have attempted to distinguish between these hypotheses by carrying out the mixing experiments shown in course in the variant lines as in wild-type HTC cells.",13 Because the induction of tyrosine aminotransferase requires an intact glucocorticoid receptor capable of being translocated to the nucleus, these observations suggest that the proximal steps in the glucocorticoid receptor pathway are intact in these variants, and that the resistance is due to a more distal lesion in the pathway of hormonal inhibition of PA.
The selectivity of the hormone resistance in these variants has been studied by examining the ability of dexamethasone to inhibit AIB transport. The velocity of AIB transport by wild-type and variant cell lines in the absence of dexamethasone was similar. Eight of nine variant Lines tested showed wild-type inhibition of AIB Thus these variants do not show a general resistance to all membraneassociated dexamethasone responses, and it can be concluded that these two membrane properties are independently regulated by dexamethasone. Interestingly, one variant did show partial resistance to inhibition of AIB transport by dexamethasone; this resistance was manifest even at concentrations of dexamethasone as high 10
pM.I3
Role of Plasminogen Activator in the Dexamethasone
Regulation of Cellular Adhesiveness
We have utilized the dexamethasone-resistant variants to analyze the mechanism of dexamethasone regulation of other membrane properties, such as the induction of adhesion in HTC cells. ' We have directly tested the hypothesis that dexamethasone induces cell adhesiveness by decreasing the activity of plasmhogen activator, which, in turn, allows the accumulation of specific membrane glycoproteins necessary for adhesion. If this hypothesis were correct, there should be little or no dexamethasone induction of adhesion in the variant cell lines resistant to the inhibition of PA. We have reported that, in fact, dexamethasone induces the adhesiveness of three of three variant HTC cell lines tested to a similar extent as in wild-type cells?" Experiments with one variant are shown in FIGURE 5. These observations suggest that the dexamethasone induction of adhesion probably operates primarily through the synthesis of cell surface glycoproteins and that this process in turn is not regulated by the inhibition of PA activity.
Thus, dexamethasone-resistant variant cell l i e s have been useful in studying the role of proteases in the hormonal regulation of other membrane functions. In the case of the induction of cellular adhesiveness, they have allowed the clear exclusion of a plausible hypothesis for the mechanism of induction of adhesiveness. Studies with these variants also indicate that the inhibition of AIB transport is not secondary to an inhibition of PA activity, since variants resistant to the latter effect retain normal inhibition of transport. Because these variant cell lines also retain wild-type induction of tyrosine aminotransferase as well as inhibition of amino acid transport and induction of adhesiveness, it appears the process or processes in hormonal regulation that are defective in these variants are not shared in the regulation of other hormone-induced events. Such a conclusion is also supported by our studies with Thompson et 01. utilizing other HTC cell variants in which tyrosine aminotransferase is not inducible. These noninducible variants have retained wild-type glucocorticoid regulation of such membrane properties as AIB transport and PA activity?' Cell hybridization experiments between variants resistant to enzyme induction and others resistant to the inhibition of PA activity should help in unraveling the mechanisms by which glucocorticoids regulate these functions in HTC cells. synthesis of membrane and secretory proteins in dexamethasone-treated wild-type cells with those in variant cells with selective lesions in hormone responsiveness should help in both the identification and isolation of specific hormonally-induced proteins.
